CD86 anticorps

N° du produit ABIN135273

Cet anticorps anti-CD86 est un anticorps Rat Monoclonal détectant CD86 dans FACS. Adapté pour Souris. Ce Primary Antibody a été cité dans 1 publication.

Aperçu rapide pour CD86 anticorps (ABIN135273)

Antigène: CD86

Reactivité: Souris

Hôte: Rat

Clonalité: Monoclonal

Conjugué: Cet anticorp CD86 est non-conjugé

Application: Flow Cytometry (FACS)

Clone: GL1

Détail du produit anti-CD86 anticorps

Specificité: Mouse CD86, Mr 80 kDa

Attributs du produit: Rat Anti-Mouse CD86-UNLB

Purification: Purified

Immunogène: LPS-activated CBA/Ca mouse spleen B cells

Isotype: IgG2a

Information d'application

Indications d'application:

• Applications: FC - Quality tested , IHC-FS - Reported in literature , IP - Reported in literature , Block - Reported in literature
• Working Dilutions: Flow Cytometry FITC, BIOT, and AF488 conjugates 1 g/106 cells PE, APC, SPRD, PE/CY7, AF647, and AF700 conjugates 0.1 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L

Commentaires:

In vivo and in vitro blocking assays

Volume d'échantillon: 1 mL

Restrictions: For Research Use only

Stockage

Concentration: 0.5 mg/mL

Buffer: 0.5 mg of purified immunoglobulin in 1.0 mL of borate buffered saline,  pH 8.2. No preservatives or amine-containing buffer salts added

Agent conservateur: Without preservative

Conseil sur la manipulation: Each reagent is stable for the period shown on the bottle label if stored as directed.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C

Références pour anticorps anti-CD86 (ABIN135273)

Ma, Martínez-Ramírez, Borders, Gao, Sosa-Pineda: "Metabolic and non-metabolic liver zonation is established non-synchronously and requires sinusoidal Wnts." dans: eLife, Vol. 9, (2020) (PubMed).

Détails sur CD86

Antigène: CD86

Autre désignation: CD86

Sujet: CD86, also known as B7-2, is a type I transmembrane glycoprotein and a member of the immunoglobulin superfamily of cell surface receptors. It is expressed at high levels on resting peripheral monocytes and dendritic cells and at very low density on resting B and T lymphocytes. CD86 expression is rapidly upregulated by B-cell specific stimuli with peak expression at 18-42 hours after stimulation. CD86, along with CD80/B7-1, is an important accessory molecule in T cell costimulation via its interaction with CD28 and CD152/CTLA-4. Since CD86 has rapid kinetics of induction, it is believed to be the major CD28 ligand expressed early in the immune response.

Pathways: TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation